bright subset or placed somewhere else in the NK cell differentiation and maturation pathway.
bright subset is considered as the most cytotoxic one. In peripheral blood of healthy donors, we noticed the existence of a population of CD56 dim CD16 dim NK cells that was frequently higher in number than the CD56 bright subsets and even expanded in occasional control donors but also in transporter associated with antigen processing-deficient patients, two familial hemophagocytic lymphohistiocytosis type II patients, and several common variable immunodeficiency patients. This population was detected but globally reduced in a longitudinal cohort of 18 − NK cells. The population was also identified in various organs of immunodeficient mice with a human immune system ("humanized" mice) reconstituted from human cord blood stem cells. In conclusion, the CD56 dim CD16
dim NK cell subpopulation displays distinct phenotypic and functional features. It remains to be clarified if these cells are the immediate precursors of the CD56 dim CD16
bright subset or placed somewhere else in the NK cell differentiation and maturation pathway. (ii) antibody-dependent cellular cytotoxicity (ADCC) against antibody-coated target cells, and (iii) cytokine and chemokine production and secretion, which not only are important in innate immunity but also influence the subsequent adaptive immune response (1) . Considered for decades as exclusively innate lymphocytes, NK cells have been shown to display memory functions as well (2) (3) (4) . In addition, they can act as suppressive cells under certain conditions (5) . Whereas a totally specific and selective NK cell marker does not exist, human NK cells are usually described as CD3 − CD56
+ large granular lymphocytes. They can be divided into several subpopulations based on the expression of CD56 (an adhesion molecule) and the ADCC-mediating FcγRIIIA receptor CD16 (6) (7) (8) . In peripheral blood, the numerically major subpopulation is CD56 dim CD16 bright (≥90% of total NK cells) and is frequently described as the most cytotoxic subset, whereas CD56 bright CD16 dim/− NK cells are abundant cytokine producers. Although this is still debated, the majority of authors consider the latter as the immature precursor cells of the CD56 dim CD16 bright population. Peripheral blood furthermore contains some CD56 dim CD16
− and CD56 − CD16 bright NK cells (9) (10) (11) . From the functional point of view, NK cells degranulate their cytotoxic vesicles upon encounter with susceptible target cells, a phenomenon that can be measured by flow cytometry with an antibody directed against the vesicle-associated protein CD107a and that reflects cytotoxic activity (12) . Furthermore, it has been demonstrated that upon activation, several CD56 dim CD16 bright NK cells lose the expression of CD16 through metalloproteasemediated shedding and become CD56 dim CD16 − (13), so that the highest percentage of CD107a + degranulating cells is found among the latter population.
The phenotype of the various NK cell subpopulations in terms of repertoires of activating and inhibitory receptors as well as cytokine/chemokine receptors and adhesion molecules is not the same, and this is the basis for their different functional and migratory behavior (14) . Thus, for example, CD56 bright CD16 dim/− NK cells are the predominant subset in lymph nodes (LN) (15) .
The best studied NK cell inhibitory receptors are specific for human leukocyte antigen (HLA) class I molecules; whereas the killer immunoglobulin receptors (KIR) recognize groups of classical HLA class I alleles, NKG2A binds to the non-polymorphic and non-classical molecule HLA-E. If a developing NK cell expresses one or several self-specific inhibitory receptors, it becomes licensed (educated) and functional (16) . In the absence of such a receptor, the NK cell remains unlicensed and hyporesponsive, although it is now recognized that these cells can rapidly become efficient if appropriately stimulated, and that the unlicensed status may actually be advantageous under certain conditions (17) .
Natural killer cells go through several maturation stages, progressively losing NKG2A but acquiring KIR and CD57 until reaching the terminal CD56 dim KIR +
CD57
+ phenotype. These cells are functional after interaction with target cells but do not proliferate well any more (18) . Although a truly specific maturation marker is still missing, CD226 (DNAM-1) is considered as a molecule characterizing educated, self-specific inhibitory receptor expressing NK cells (18) .
By closely examining CD56 versus CD16 flow cytometry dot plots, we noticed the presence of a CD56 dim CD16 dim population numerically minor compared with the CD56 dim CD16 bright NK cells but nevertheless clearly identifiable in a majority of healthy donors (HD). These cells were expanded in transporter associated with antigen processing (TAP)-deficient patients, in some familial hemophagocytic lymphohistiocytosis type II (FHL II), and common variable immunodeficiency (CVID) patients but not in HIV1-infected patients. We also investigated three cases of multiple myeloma (MM) in this regard.
Human TAP deficiency is an autosomal recessive immune defect characterized by a very low cell surface expression of HLA class I molecules and clinically by chronic bacterial infections of the respiratory tract, bronchiectasis, and granulomatous skin lesions, sometimes accompanied by a midface involvement leading to a total destruction of the nasal cartilage (19, 20) . Approximately 30 cases have been described to date, but there are probably many more if one considers the high number of idiopathic bronchiectasis cases (21) and the often reduced access to healthcare in regions where consanguinity is frequent. NK cells are numerically normal in this disease but overexpress inhibitory receptors and combinations thereof (22, 23) . Functionally, NK cells are hypo-responsive at baseline (they are not educated due to the lack of HLA class I molecules in the environment) but auto-aggressive after cytokine-mediated activation, thus potentially contributing to the chronic inflammatory state of this condition (20, 22, 24) .
Familial hemophagocytic lymphohistiocytosis corresponds to a group of rare autosomal recessive immunodeficiencies with defective cytotoxic cells and an over-activation of macrophages. They are the so-called "cytokine storm" syndromes, as the macrophages are activated by very high levels of pro-inflammatory cytokines (25) (26) (27) . Among the five types described, FHL II is due to a mutation in the perforin gene (25) (26) (27) .
Common variable immunodeficiency is more frequent and is described as a defect in immunoglobulin production with or without T cell abnormalities (28) . A recent study by Ebbo et al. (29) concluded that the clinical severity of the disease is most important in patients with an additional severe NK cell lymphopenia, implicating a protective role of NK cells when present in normal numbers.
Numerous effects of HIV-1 infection on NK cells have been described, and they are only partly restored by combined antiretroviral therapy (cART). Notably, an increase in the CD56 − CD16 bright population is frequently observed, these cells being functionally deficient (30) (31) (32) .
In this paper, we report the phenotypic and functional characterization of the CD56 dim CD16 dim NK cell subset.
MaTerials anD MeThODs sample collection
Blood samples from HD, HIV-1-infected patients, and TAP-deficient patients were collected, and peripheral blood mononuclear cells (PBMC) were isolated by centrifugation over a Ficoll-Hypaque gradient with Lymphoprep (Elitech). PBMC were either used immediately or frozen (10 × 10 6 cells/ml) in liquid nitrogen using Recovery Cell Culture Freezing Medium (Invitrogen). Blood samples of HIV-1-infected patients were processed in a BSL3 laboratory. Longitudinal samples of HIV-1-infected patients when viremic before antiretroviral therapy and aviremic under cART for a minimum of 12 months and with a viral load <40 copies/ml were collected (Table S1 in Supplementary Material). Collection was done in accordance with the Declaration of Helsinki from the HD and the patients who each gave informed consent. The study was approved by the National Research Ethics Committee of Luxembourg (CNER, approval numbers 201109/05 and 201209/01). For the pediatric FHL II and CVID patients from Colombia, parents signed the informed consent forms (ethics approval numbers 07-07-111 and 10-7-311, respectively). Only fresh blood was used for this part of the study.
Multicolor Flow cytometry
Fresh or thawed cells were stained with conjugated antibodies, listed in Table S2 in Supplementary Material, for 30 min at 4°C in the dark. Stained blood was incubated with BD FACS Lysing Solution (BD Biosciences) for 10 min to lyse red blood cells. After two washes, samples were read on a FACS Fortessa SORP 5 laser instrument (BD Biosciences) and analyzed with the Kaluza Flow Cytometry Analysis Software (Beckman Coulter). Dead cells, monocytes, and T and B lymphocytes were gated out, and NK cell subpopulations were analyzed based on the differential expression of CD56 and CD16. In order to reduce inter-experimental variations, an HD sample was included in each staining in parallel to samples from all patient cohorts.
Degranulation assay
Total PBMC or sorted NK cell subsets were incubated for 5 h with K562 cells at an E:T ratio of 7:1. After 1 h of incubation, GolgiStop™ and GolgiPlug™ (BD Biosciences) were added. Negative and positive controls without K562 cells were also included. PMA (Invivo Gen) and ionomycin (Life Technologies) were used for the positive condition at 50 and 500 ng/ml, respectively (data not shown). The anti-CD107a antibody was incubated with the cells during the 5 h of incubation. Finally, surface staining and IFN-γ intracellular staining (Table S2 in Supplementary Material) were performed.
For cell sorting, fresh or cryopreserved PBMC from HD were used. NK cells were separated using the MACS NK Cell Isolation Kit (Miltenyi Biotec) according to the manufacturer's instructions. NK cells were stained with anti-CD56 (clone NCAM16.2) and anti-CD16 (clone VEP13) antibodies. In order to avoid NK cell activation, the anti-CD16 clone VEP13 mAb was used for the cell sorting (33 bright subpopulations were aseptically sorted on a FACSAria cell sorter (BD Biosciences) and rested overnight in RPMI-1640 medium supplemented with 10% FBS and antibiotics prior to the degranulation assay. Before the degranulation assays, NK cells were restained with anti-CD56 (clone NCAM16.2) and anti-CD16 (clone VEP13) antibodies.
The myeloid leukemia cell line K562 was purchased from the ECACC and cultured in RPMI-1640 medium supplemented with 10% FBS and antibiotics.
generation of nsg and nsg hla-a2 humanized Mice NSG (NOD/LtSz-scid/IL2Rγnull) and NSG HLA-A2 (NOD. Cg-Prkdcscid Il2rgtm1Wjl Tg (HLA-A/H2-D/B2M)1Dvs/SzJ) mice were purchased from Jackson Laboratory, USA. Mice were bred and kept in a specific pathogen-free animal facility. All animal experiments were performed in accordance with the Animal Welfare Committee of LIH (protocol number LRTV 1402) and complied with the national legislation and guidelines for animal experimentation. Humanized NSG and NSG HLA-A2 mice were generated as previously described (34) . Six months posttransplantation, mice were euthanized. Tissues and blood samples were processed immediately. LN, spleen, and bone marrow were dissociated with syringes and passed through a nylon cell strainer to obtain single-cell suspensions. Lungs were digested 45 min at 37°C with collagenase A and DNase I recombinant grade I (Sigma-Aldrich) in HBSS (Lonza). Single-cell suspensions were obtained by passing the digested tissue through a 18 G needle and a nylon cell strainer. Red blood cells were lysed using human erythrocyte lysing solution, and samples were washed twice with RPMI-1640. Cells were re-suspended in FACS buffer (PBS, 5% FBS) and stained with the appropriate antibodies as described above.
statistics
All results presented in this paper were expressed as mean ± SEM, with the number of biological replicates indicated for each cohort either in the text and/or in the figure legends. A probability level of ≤0.05 was considered significant. We used Wilcoxon matchedpairs signed rank tests for the comparisons between individual NK cell subsets within a cohort and Mann-Whitney t-tests for the comparison of individual NK cell subsets between HD and patients. Wilcoxon matched-pairs signed rank tests were also used for the comparison of individual NK cell subsets between longitudinal samples of HIV-1-infected patients when viremic naïve to cART and aviremic under cART. All graphs and statistical analyses were performed using Graphpad Prism 5.0 (Graphpad Software, La Jolla, CA, USA). were found to express CD7 in each healthy donor and are therefore considered as NK cells and not as CD56 + CD7 − myeloid cells (data not shown) (35) .
We next investigated if this NK cell subpopulation could also be detected in immunodeficiencies such as HIV infection and whether it had a distinct phenotype. NK cell populations from frozen PBMC of HD (n = 12) and longitudinal paired samples of HIV-1-infected patients when viremic naïve to cART and aviremic under cART (n = 18, Figures 2A-C) were analyzed by multicolor flow cytometry. As shown in Figure 2D , the CD56 dim CD16 dim FigUre 3 | Percentages relative to the total natural killer (NK) cell population (100%) of different blood NK cells subsets expressing the markers KIR2DL2/DL3/DS2, KIR2DL1/DS1, KIR3DL1, NKG2A, and CD57 from frozen peripheral blood mononuclear cells of a cohort of healthy donors (n = 12) (*p < 0.05; **p < 0.01; ***p < 0.001). dim NK cells was observed in thawed PBMC from HD and HIV-infected patients, greater than the one found in fresh samples (36) .
As previously described, HIV-1 infection dramatically altered the distribution of NK cell subsets, with, respectively, reducing and increasing the percentages of CD56 dim and anergic CD56 − NK cells in viremic patients [ Figure 2E ; (30, 31) ]. Both of these abnormalities were reverted by cART (32) . Interestingly, among the CD56 dim NK cell subsets, only the CD56 dim CD16 dim proportion was significantly reduced by HIV-1 infection and was not restored by cART, suggesting that this subset was more affected by the infection than the other CD56 dim subpopulations ( Figure 2D (Figure 3) , KLRG1 ( Figure S1 in Supplementary Material) and a higher expression of NKG2A (Figure 3) , CD27, and CD62L ( Figure  S1 in Supplementary Material). All the multicolor flow cytometry data are presented in Table S3 dim NK cells (38) , the staining for NKG2A did not vary before and after freezing/thawing in any of the subpopulations analyzed. In the case of CD226 and KLRG1, however, there was a trend toward a higher expression on thawed cells, but only in the CD56 dim CD16
− subset ( Figure S3 in Supplementary Material).
Since the CD56 dim CD16 dim subset was, among all CD56 dim cells, the most affected by HIV-1 infection, we next investigated whether the expression of a large set of markers in this population could be differentially affected and distinguish its phenotype as compared to the other NK cell subsets (Figure 4) . bright NK cells, showed a massively decreased expression of SIGLEC-7 and NKp30 in viremic patients. In contrast to HD, in viremic patients, no differences were observed between CD56 dim NK subsets in terms of SIGLEC-7 expression, whereas (Figure 4 ; Figure  S6 in Supplementary Material). KIR2DL1/DS1 expression was slightly restored in all CD56 dim subsets in patients when aviremic under cART (Figure 4) (Figures 5A,B) . The CD56 dim CD16
− population was similarly the most effective subset to produce IFN-γ. In viremic HIV-1-infected patients, CD107a expression was found to be impaired in CD56 dim CD16
− NK cells upon stimulation with K562 cells. The IFN-γ production was also impaired in all CD56 dim subsets at basal level and in CD56 dim CD16 dim and CD56 dim CD16 − NK cells after stimulation with K562. Combined ART restored neither CD107a expression nor IFN-γ production (Figures 5C,D) .
Stimulation with K562 can induce the loss of CD16 expression on a large part of NK cells (13, 36 bright cells that have begun to lose CD16 expression. To further confirm our results, we sorted the different CD56 dim populations separately by starting from fresh HD PBMC (n = 4) and then assessed their degranulation and cytokine production in response to K562 cell stimulation ( Figure 6A) . In one HD, the CD56 dim CD16
− NK cells were almost absent, and no data were obtained for this subset. In line with our previous observations, the CD107a staining showed a tendency toward an increased degranulation from CD56 dim CD16 bright to − NK cells were already able to degranulate without K562 cells at quite a high level ( Figure 6B) . In terms of IFN-γ production, although we observed the same tendency at basal levels, in the stimulated condition, we were not able to observe significant differences between the three subsets ( Figure 6C) .
We next investigated the presence of the CD56 dim CD16 dim NK cells in other immunodeficiencies than HIV infection. We found CD56 dim CD16 dim NK cells to be not only present but even expanded in the blood of seven patients with TAP deficiency (Figures 7A,C) compared with normal donors (Figures 7B,C) . In parallel, we observed a diminution in the percentage of cells in the CD56 + hematopoietic stem cells from cord blood after myelosuppression and reconstitute a human immune system within several months (41, 42) . Six months after transplantation, three standard NSG mice and two NSG mice transgenic for the classical HLA class I molecule HLA-A2 showed a good engraftment (89-94% of human CD45 + cells in spleen) and displayed human monocytes, B cells, T cells, and CD3
− cells in peripheral blood ( Figure 8A ) as previously described (43) . NK cell subpopulations defined by CD56 and 
DiscUssiOn
In this paper, we describe CD56 A major problem when studying CD16 is that this molecule is quickly shed from the NK cell surface upon activation due to the action of metalloproteases (13) . This could very well explain why the majority of degranulating cells are found within the CD56 dim CD16
− subset. Such a phenomenon has been previously described (36) . Furthermore, under these conditions, CD56 dim CD16 dim NK cells are likely a mixture of relatively bright subsets is admitted by most authors, as most recently discussed by Mace (44) , the latter population being further subdivided into more or less terminally differentiated subtypes (9) . Based on this model and on their relatively immature phenotype revealed in this study, one might consider the CD56 Another point to be discussed is the fact that if one assumes that in the functional assays, the cells with the most immature phenotype were also those that contained the highest fraction of degranulating cells (the CD56 dim CD16
− fraction), this would suggest that immaturity does not necessarily correlate with absence of functionality and would be reminiscent of the high cytokine producing capacity of the phenotypically immature CD56 bright CD16
− NK cells (11 versus CD56 flow cytometry dot plots in several papers, but it is always gated together with the CD56 dim CD16 bright subset. Likely closely related to this population are the NK cells described by Lima et al. (48) , but these authors discriminate their subset on the basis of the expression level of CD56, which is higher than that on the CD56 dim CD16 bright cells. Furthermore, Krzywinska et al. distinguish NK cell subpopulations according to the CD45 isoforms expressed. They also show CD56 dim CD16 dim cells, but here again, the CD56 dim CD16 − subset is included in the gating (49) .
Humanized mice are becoming increasingly important in immunology, for example as models allowing HIV infection and subsequent drug evaluation in small animals. The engraftment of NK cells under these conditions is not always optimal, so that some groups use exogenous human IL15/IL15Rα complexes or human cytokine gene knock-ins to improve the NK cell yield (41, 42, 50) . Without any of such methods, we reproducibly observed between 6 and 11% of total living human CD45 + cells being negative for lineage markers such as CD3, CD14, and CD19. Among them, the CD56 dim CD16
dim population interestingly showed up in all the organs tested and was even sometimes relatively abundant, which might suggest that the immune system of these mice was not yet fully mature at the time of sacrifice, with a relatively high amount of CD56 dim NK cells still in the precursor phase. Alternatively, NK cells could be spontaneously activated in this model to some extent and the CD56 dim CD16 dim subset represents cells in the process of completely losing CD16. The NK cells from the humanized mice were quite functional in terms of degranulation but did not produce IFN-γ, as previously described for the NSG model by Rongvaux et al. (42) . In addition, it is well known that not all NK cells are cytotoxic and cytokine producers at the same time (51) . The various subpopulations could not be FACS-sorted due to the rarity of NK cells in this model that needs further improvement.
The question arises as to why the CD56 dim CD16 dim subset was so dramatically upregulated in TAP deficiency as well as in some cases of FHL II and CVID, and occasionally, in HD. In the former, we have previously described an expansion of the CD56 bright population that might be due to a higher amount of precursor cells due to the chronic infectious state of these patients needing a continuous replenishment with new NK cells (52) . Under these conditions, it would not be unexpected to also observe an increase in the CD56 dim CD16 dim precursors, and the same could be true for the other primary immunodeficiencies. On the other hand, considering the interesting possibility that CD56 bright and CD56 dim NK cells originate from two different lineages, the CD56 dim CD16 dim population would accumulate for the same reasons in these patients but would, at least in part, directly stem from the original CD56 dim precursor. There might also be a partial block in the final maturation step of NK cells in these diseases, as previously suggested for TAP deficiency (23) , leading to an increased precursor frequency in some cases. − subtypes expressing the markers NKG2C, NKG2D, NKp30, SIGLEC-7, CD244, CD38, CD27, CD69, CD62L, CD8, human leukocyte antigen-DR, KLRG1, and CD226 from frozen peripheral blood mononuclear cells of a cohort of healthy donors (n = 12 for all markers except for KLRG1 and CD226, n = 6) (*p < 0.05; **p < 0.01; ***p < 0.001). − subtypes expressing the markers KIR2DL2/ DL3/DS2, NKG2A, and CD57 from frozen peripheral blood mononuclear cells. − subtypes expressing the marker SIGLEC-7 from frozen peripheral blood mononuclear cells. 
